More specifically, this study found that the combination of anti-IL-1β and anti-PD-1 treatment does not slow primary tumor growth but reduces lung metastasis rate and prolongs overall survival in PDAC orthotopic murine model with lung metastasis tropism. The gene discussed is IL1B; the disease is neoplasm.